Analysing big data to predict men’s risk of side effects could help personalise radiotherapy treatment for prostate cancer.
Men with unusually low amounts of testosterone in their blood are around 20% less likely to develop prostate cancer.
Availability of robotic prostate cancer surgery could be a bigger draw for patients than quality of hospital
Prostate cancer patients may base choice of hospital for surgery on availability of new technology, rather than hospital quality information, according to study
From this week’s cancer news we look at how HIV research could offer clues about lung cancer and bust headlines about a radiotherapy ‘cure’ for prostate cancer.
A form of radiotherapy targeting the pelvis is safe for men with advanced localised prostate cancer, according to a new study.
Unpublished results from the Cancer Research UK-funded STAMPEDE trial show that two different treatments improve survival in men with advanced prostate cancer.
Physicists in Cambridge are using light and sound to gather information on prostate cancer in mice. This could show doctors how aggressive a tumour is.
A new imaging technique uncovers oxygen levels in prostate tumours and could lead to a non-invasive way to determine which tumours are more difficult to treat.
Read Alfred's story of joining the STAMPEDE clinical trial. His is one of the many stories featured in our 2016/17 Annual Review.
Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine.